This $1,645,000 federal Project Grant award, provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research by The Trustees of Columbia University in the City of New York to investigate treating HER2 therapy-resistant brain metastasis using antidepressants. The research aims to transform healthcare for military service members and the broader public by exploring innovative approaches to...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $2,056,250.00 to The Trustees of Columbia University in the City of New York for the project "TARGETING CERVICAL EPIDURAL SPINAL CORD STIMULATION FOR FUNCTIONAL RECOVERY". The award period runs from September 1, 2024 to August 31, 2027. The project aims to conduct advanced biomedical research focused on transforming...
This $1,645,000.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program supports advanced biomedical research at The Trustees of Columbia University in the City of New York, focused on "BONE FRACTURE-INDUCED JOINT BLEEDING AND POSTTRAUMATIC OSTEOARTHRITIS". The award period runs from May 1, 2025 through April 30, 2028, and aims to transform healthcare for military service members and the general...
The Trustees of Columbia University in the City of New York, doing business as Health Sciences Division, was awarded a $656,272 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports research aimed at optimizing PD-1 immunotherapy through increased T cell regeneration and reduced antigen load. This 2-year project will be conducted in New York, NY from September 1, 2023 to August 31, 2025. The Military Medical...
This $4,343,333 federal Project Grant award from the Defense Health Agency, under the Military Medical Research and Development (CFDA 12.420) program, supports Drexel University's research on mild traumatic brain injury-related vision disorders. The key objectives are to develop a patient-reported outcome measure (PROM), validate clinical outcome measures, study the natural history of these conditions, and explore interventions. This multiyear effort, running from September 2024 through...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $1,493,233 to The Trustees of Columbia University in the City of New York to fund research on gene therapy in a nonhuman primate model of cognitive defects in Parkinson's disease. The award commenced on November 15, 2024 and is set to be completed by November 14, 2027. The university's Health Sciences Division will leverage its...
This $199,115.92 federal Project Grant award was issued on May 15, 2024 by the U.S. Department of Defense Research Development and Engineering Command (RDECOM) under the Basic Scientific Research program (CFDA 12.431). The award supports foundational and applied research across a broad spectrum of scientific and technical domains, with the goal of advancing fundamental knowledge and developing capabilities with potential military applications. The grant recipient is The Trustees of Columbia...
This federal Project Grant award in the amount of $197,400.00, funded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports the development of patient-derived central nervous system (CNS) metastasis models with STK11 inactivation for drug discovery. The award was granted to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, a prominent academic research institution. The project...
This federal Project Grant award of $410,800 from the Defense Health Agency under the Military Medical Research and Development Program (CFDA 12.420) is supporting the "Restoration of Visual Function Using Optic Nerve Relays" research project at the University of California, San Diego (UCSD). The project aims to advance medical solutions and healthcare for military service members and the general public through innovative biomedical research in neuroscience and vision restoration....
The University of Southern California will receive $1,209,550 under a three-year Project Grant award from the Department of the Army Medical Command. The grant falls under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to improve health care for service members and the public. Specifically, USC will develop wearable early intervention electric stimulation technology for optic nerve regeneration. The...